|
|
negative regulation of transcription from rna polymerase ii promoter
|
GO:0000122 |
281 |
1.000
|
|
|
|
cellular response to dna damage stimulus
|
GO:0006974 |
379 |
1.000
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
268 |
1.000
|
|
|
|
positive regulation of cysteine type endopeptidase activity involved in apoptotic process
|
GO:0043280 |
69 |
1.000
|
|
|
|
positive regulation of proteolysis
|
GO:0045862 |
142 |
1.000
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
78 |
1.000
|
|
|
|
regulation of mitotic cell cycle
|
GO:0007346 |
189 |
1.000
|
|
|
|
negative regulation of apoptotic process
|
GO:0043066 |
316 |
1.000
|
Zebrafish |
|
|
negative regulation of cell death
|
GO:0060548 |
345 |
1.000
|
Zebrafish |
|
|
positive regulation of programmed cell death
|
GO:0043068 |
249 |
1.000
|
|
|
|
negative regulation of mitotic cell cycle
|
GO:0045930 |
102 |
1.000
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
393 |
1.000
|
|
|
|
mitotic cell cycle checkpoint
|
GO:0007093 |
68 |
1.000
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
213 |
1.000
|
|
|
|
mitotic g1 dna damage checkpoint
|
GO:0031571 |
17 |
1.000
|
|
|
|
dna repair
|
GO:0006281 |
198 |
1.000
|
|
|
|
cell cycle phase transition
|
GO:0044770 |
173 |
1.000
|
|
|
|
protein ubiquitination
|
GO:0016567 |
314 |
1.000
|
|
|
|
g1 s transition of mitotic cell cycle
|
GO:0000082 |
78 |
1.000
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
293 |
1.000
|
|
|
|
positive regulation of cysteine type endopeptidase activity
|
GO:2001056 |
79 |
1.000
|
|
|
|
response to abiotic stimulus
|
GO:0009628 |
336 |
1.000
|
|
|
|
regulation of cell cycle phase transition
|
GO:1901987 |
126 |
1.000
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
175 |
1.000
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
263 |
1.000
|
|
|
|
mitotic cell cycle process
|
GO:1903047 |
286 |
1.000
|
|
|
|
activation of cysteine type endopeptidase activity involved in apoptotic process
|
GO:0006919 |
49 |
1.000
|
|
|
|
negative regulation of cell cycle
|
GO:0045786 |
193 |
0.999
|
|
|
|
negative regulation of cell cycle process
|
GO:0010948 |
121 |
0.999
|
|
|
|
nervous system development
|
GO:0007399 |
293 |
0.999
|
|
|
|
mitotic cell cycle phase transition
|
GO:0044772 |
162 |
0.999
|
|
|
|
regulation of cell cycle arrest
|
GO:0071156 |
36 |
0.999
|
|
|
|
regulation of cell cycle g1 s phase transition
|
GO:1902806 |
42 |
0.999
|
|
|
|
negative regulation of programmed cell death
|
GO:0043069 |
321 |
0.999
|
Zebrafish |
|
|
zymogen activation
|
GO:0031638 |
70 |
0.999
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
246 |
0.999
|
|
|
|
regulation of cell cycle process
|
GO:0010564 |
266 |
0.999
|
|
|
|
mitotic dna damage checkpoint
|
GO:0044773 |
28 |
0.999
|
|
|
|
chromatin organization
|
GO:0006325 |
351 |
0.999
|
|
|
|
modification dependent protein catabolic process
|
GO:0019941 |
209 |
0.999
|
|
|
|
intrinsic apoptotic signaling pathway
|
GO:0097193 |
127 |
0.999
|
|
|
|
response to radiation
|
GO:0009314 |
151 |
0.999
|
Zebrafish |
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
380 |
0.999
|
|
|
|
regulation of peptidase activity
|
GO:0052547 |
180 |
0.999
|
|
|
|
positive regulation of apoptotic signaling pathway
|
GO:2001235 |
70 |
0.999
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
117 |
0.999
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
326 |
0.999
|
|
|
|
response to hypoxia
|
GO:0001666 |
96 |
0.998
|
|
|
|
activation of cysteine type endopeptidase activity
|
GO:0097202 |
57 |
0.998
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
125 |
0.998
|
|
|
|
i kappab kinase nf kappab signaling
|
GO:0007249 |
166 |
0.998
|
|
|
|
negative regulation of sequence specific dna binding transcription factor activity
|
GO:0043433 |
89 |
0.998
|
|
|
|
regulation of endopeptidase activity
|
GO:0052548 |
170 |
0.998
|
|
|
|
regulation of cell differentiation
|
GO:0045595 |
393 |
0.998
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
405 |
0.998
|
|
|
|
proteolysis involved in cellular protein catabolic process
|
GO:0051603 |
244 |
0.998
|
|
|
|
ubiquitin dependent protein catabolic process
|
GO:0006511 |
206 |
0.997
|
|
|
|
regulation of i kappab kinase nf kappab signaling
|
GO:0043122 |
162 |
0.997
|
|
|
|
rho protein signal transduction
|
GO:0007266 |
26 |
0.997
|
|
|
|
regulation of sequence specific dna binding transcription factor activity
|
GO:0051090 |
211 |
0.997
|
|
|
|
mitotic dna integrity checkpoint
|
GO:0044774 |
30 |
0.997
|
|
|
|
dna integrity checkpoint
|
GO:0031570 |
71 |
0.997
|
|
|
|
epidermis morphogenesis
|
GO:0048730 |
3 |
0.997
|
|
|
|
cell cell signaling
|
GO:0007267 |
155 |
0.996
|
|
|
|
positive regulation of cellular catabolic process
|
GO:0031331 |
284 |
0.996
|
|
|
|
mitotic g1 s transition checkpoint
|
GO:0044819 |
17 |
0.996
|
|
|
|
hematopoietic or lymphoid organ development
|
GO:0048534 |
186 |
0.995
|
|
|
|
regulation of cytoskeleton organization
|
GO:0051493 |
177 |
0.995
|
|
|
|
g1 dna damage checkpoint
|
GO:0044783 |
18 |
0.995
|
|
|
|
signal transduction involved in mitotic cell cycle checkpoint
|
GO:0072413 |
13 |
0.995
|
|
|
|
positive regulation of cell cycle arrest
|
GO:0071158 |
23 |
0.995
|
|
|
|
response to biotic stimulus
|
GO:0009607 |
276 |
0.995
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
437 |
0.995
|
|
|
|
dna replication
|
GO:0006260 |
116 |
0.994
|
|
|
|
regulation of actin filament based process
|
GO:0032970 |
141 |
0.994
|
|
|
|
positive regulation of endopeptidase activity
|
GO:0010950 |
84 |
0.994
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
412 |
0.994
|
|
|
|
regulation of mitotic cell cycle phase transition
|
GO:1901990 |
118 |
0.993
|
|
|
|
negative regulation of g1 s transition of mitotic cell cycle
|
GO:2000134 |
29 |
0.993
|
|
|
|
embryonic morphogenesis
|
GO:0048598 |
85 |
0.993
|
|
|
|
regulation of myeloid cell differentiation
|
GO:0045637 |
81 |
0.993
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
411 |
0.993
|
|
|
|
intrinsic apoptotic signaling pathway in response to dna damage
|
GO:0008630 |
50 |
0.992
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
331 |
0.992
|
|
|
|
positive regulation of cell proliferation
|
GO:0008284 |
301 |
0.992
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
408 |
0.992
|
|
|
|
cellular response to hypoxia
|
GO:0071456 |
51 |
0.991
|
|
|
|
proteasome mediated ubiquitin dependent protein catabolic process
|
GO:0043161 |
156 |
0.990
|
|
|
|
ribosome biogenesis
|
GO:0042254 |
48 |
0.990
|
|
|
|
cellular response to abiotic stimulus
|
GO:0071214 |
117 |
0.990
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
413 |
0.990
|
|
|
|
regulation of cysteine type endopeptidase activity involved in apoptotic process
|
GO:0043281 |
116 |
0.989
|
|
|
|
dna damage checkpoint
|
GO:0000077 |
68 |
0.989
|
|
|
|
epithelium development
|
GO:0060429 |
227 |
0.988
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
405 |
0.988
|
|
|
|
negative regulation of mitotic cell cycle phase transition
|
GO:1901991 |
85 |
0.988
|
|
|
|
regulation of proteasomal protein catabolic process
|
GO:0061136 |
87 |
0.988
|
|
|
|
modification dependent macromolecule catabolic process
|
GO:0043632 |
212 |
0.988
|
|
|
|
positive regulation of i kappab kinase nf kappab signaling
|
GO:0043123 |
132 |
0.987
|
|
|
|
proteasomal protein catabolic process
|
GO:0010498 |
176 |
0.987
|
|
|
|
positive regulation of cell cycle
|
GO:0045787 |
140 |
0.987
|
|
|
|
regulation of intrinsic apoptotic signaling pathway
|
GO:2001242 |
72 |
0.987
|
|
|
|
tube morphogenesis
|
GO:0035239 |
95 |
0.986
|
|
|
|
signal transduction involved in cell cycle checkpoint
|
GO:0072395 |
16 |
0.986
|
|
|
|
cellular response to uv
|
GO:0034644 |
32 |
0.985
|
|
|
|
response to other organism
|
GO:0051707 |
261 |
0.985
|
|
|
|
cell development
|
GO:0048468 |
328 |
0.985
|
|
|
|
protein catabolic process
|
GO:0030163 |
325 |
0.985
|
|
|
|
negative regulation of cell cycle phase transition
|
GO:1901988 |
89 |
0.984
|
|
|
|
positive regulation of cellular protein catabolic process
|
GO:1903364 |
37 |
0.983
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
379 |
0.983
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
422 |
0.983
|
|
|
|
cell cycle arrest
|
GO:0007050 |
71 |
0.982
|
|
|
|
oxidative stress induced premature senescence
|
GO:0090403 |
3 |
0.982
|
|
|
|
leukocyte migration involved in inflammatory response
|
GO:0002523 |
2 |
0.982
|
|
|
|
tissue morphogenesis
|
GO:0048729 |
96 |
0.981
|
|
|
|
regulation of cell migration
|
GO:0030334 |
289 |
0.980
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
406 |
0.980
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
408 |
0.980
|
|
|
|
positive regulation of peptidase activity
|
GO:0010952 |
88 |
0.979
|
|
|
|
chromatin modification
|
GO:0016568 |
298 |
0.978
|
|
|
|
positive regulation of catabolic process
|
GO:0009896 |
310 |
0.978
|
|
|
|
cellular response to decreased oxygen levels
|
GO:0036294 |
51 |
0.977
|
|
|
|
intracellular receptor signaling pathway
|
GO:0030522 |
104 |
0.976
|
|
|
|
cell junction organization
|
GO:0034330 |
79 |
0.976
|
|
|
|
cell cycle checkpoint
|
GO:0000075 |
117 |
0.975
|
|
|
|
response to oxygen levels
|
GO:0070482 |
100 |
0.975
|
|
|
|
positive regulation of developmental process
|
GO:0051094 |
314 |
0.975
|
|
|
|
neutrophil aggregation
|
GO:0070488 |
2 |
0.974
|
|
|
|
cellular response to endogenous stimulus
|
GO:0071495 |
336 |
0.973
|
|
|
|
regulation of rho gtpase activity
|
GO:0032319 |
66 |
0.973
|
|
|
|
regulation of protein stability
|
GO:0031647 |
87 |
0.973
|
|
|
|
protein destabilization
|
GO:0031648 |
12 |
0.973
|
|
|
|
peptidyl serine modification
|
GO:0018209 |
106 |
0.972
|
|
|
|
monosaccharide metabolic process
|
GO:0005996 |
74 |
0.971
|
|
|
|
gtp catabolic process
|
GO:0006184 |
237 |
0.971
|
|
|
|
tube development
|
GO:0035295 |
125 |
0.970
|
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
207 |
0.969
|
|
|
|
regulation of cell development
|
GO:0060284 |
161 |
0.968
|
|
|
|
positive regulation of cell differentiation
|
GO:0045597 |
211 |
0.968
|
|
|
|
signal transduction in response to dna damage
|
GO:0042770 |
57 |
0.967
|
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
391 |
0.966
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
73 |
0.964
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
430 |
0.964
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
392 |
0.962
|
|
|
|
morphogenesis of a branching structure
|
GO:0001763 |
21 |
0.962
|
|
|
|
regulation of cysteine type endopeptidase activity
|
GO:2000116 |
127 |
0.961
|
|
|
|
protein deubiquitination
|
GO:0016579 |
79 |
0.960
|
|
|
|
regulation of defense response
|
GO:0031347 |
154 |
0.960
|
|
|
|
immune system development
|
GO:0002520 |
195 |
0.959
|
|
|
|
leukocyte migration
|
GO:0050900 |
107 |
0.959
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
412 |
0.958
|
|
|
|
cellular component morphogenesis
|
GO:0032989 |
314 |
0.958
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
181 |
0.957
|
|
|
|
guanosine containing compound metabolic process
|
GO:1901068 |
244 |
0.957
|
|
|
|
regulation of proteolysis involved in cellular protein catabolic process
|
GO:1903050 |
91 |
0.956
|
|
|
|
positive regulation of defense response
|
GO:0031349 |
87 |
0.956
|
|
|
|
multicellular organismal aging
|
GO:0010259 |
3 |
0.955
|
|
|
|
regulation of g1 s transition of mitotic cell cycle
|
GO:2000045 |
40 |
0.955
|
|
|
|
regulation of cell adhesion
|
GO:0030155 |
166 |
0.955
|
|
|
|
response to external biotic stimulus
|
GO:0043207 |
261 |
0.955
|
|
|
|
cellular protein catabolic process
|
GO:0044257 |
261 |
0.954
|
|
|
|
protein modification by small protein conjugation
|
GO:0032446 |
342 |
0.954
|
|
|
|
response to xenobiotic stimulus
|
GO:0009410 |
30 |
0.951
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
398 |
0.951
|
|
|
|
endomembrane system organization
|
GO:0010256 |
196 |
0.951
|
|
|
|
protein processing
|
GO:0016485 |
226 |
0.948
|
|
|
|
urogenital system development
|
GO:0001655 |
65 |
0.947
|
|
|
|
negative regulation of reactive oxygen species metabolic process
|
GO:2000378 |
11 |
0.946
|
|
|
|
regulation of locomotion
|
GO:0040012 |
329 |
0.946
|
|
|
|
organ morphogenesis
|
GO:0009887 |
147 |
0.946
|
|
|
|
head development
|
GO:0060322 |
108 |
0.945
|
|
|
|
signal transduction involved in mitotic dna damage checkpoint
|
GO:1902402 |
13 |
0.945
|
|
|
|
regulation of cyclin dependent protein serine threonine kinase activity
|
GO:0000079 |
36 |
0.944
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
314 |
0.944
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
204 |
0.944
|
|
|
|
central nervous system development
|
GO:0007417 |
123 |
0.943
|
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
125 |
0.943
|
|
|
|
single organism membrane organization
|
GO:0044802 |
268 |
0.942
|
|
|
|
determination of adult lifespan
|
GO:0008340 |
2 |
0.941
|
|
|
|
cellular response to xenobiotic stimulus
|
GO:0071466 |
29 |
0.941
|
|
|
|
cell morphogenesis
|
GO:0000902 |
296 |
0.941
|
|
|
|
response to molecule of bacterial origin
|
GO:0002237 |
82 |
0.939
|
|
|
|
positive regulation of gtpase activity
|
GO:0043547 |
166 |
0.939
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
391 |
0.939
|
|
|
|
epithelial cell development
|
GO:0002064 |
34 |
0.934
|
|
|
|
intracellular signal transduction involved in g1 dna damage checkpoint
|
GO:1902400 |
10 |
0.934
|
|
|
|
response to decreased oxygen levels
|
GO:0036293 |
96 |
0.933
|
|
|
|
regulation of nucleotide catabolic process
|
GO:0030811 |
205 |
0.930
|
|
|
|
protein heterotetramerization
|
GO:0051290 |
3 |
0.930
|
|
|
|
positive regulation of intrinsic apoptotic signaling pathway
|
GO:2001244 |
28 |
0.928
|
|
|
|
response to nitrogen compound
|
GO:1901698 |
184 |
0.928
|
|
|
|
response to lipopolysaccharide
|
GO:0032496 |
70 |
0.923
|
|
|
|
histone modification
|
GO:0016570 |
251 |
0.923
|
|
|
|
response to cytokine
|
GO:0034097 |
232 |
0.922
|
|
|
|
apoptotic mitochondrial changes
|
GO:0008637 |
57 |
0.921
|
|
|
|
protein maturation
|
GO:0051604 |
233 |
0.919
|
|
|
|
aging
|
GO:0007568 |
66 |
0.919
|
|
|
|
regulation of nucleoside metabolic process
|
GO:0009118 |
209 |
0.919
|
|
|
|
hemopoiesis
|
GO:0030097 |
180 |
0.918
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
412 |
0.916
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
269 |
0.913
|
|
|
|
positive regulation of ras gtpase activity
|
GO:0032320 |
117 |
0.912
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
411 |
0.911
|
|
|
|
response to toxic substance
|
GO:0009636 |
37 |
0.910
|
|
|
|
cellular response to ionizing radiation
|
GO:0071479 |
32 |
0.906
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
156 |
0.906
|
|
|
|
protein autophosphorylation
|
GO:0046777 |
123 |
0.905
|
|
|
|
biological adhesion
|
GO:0022610 |
331 |
0.902
|
|
|
|
brain development
|
GO:0007420 |
97 |
0.902
|
|
|
|
regulation of reactive oxygen species metabolic process
|
GO:2000377 |
41 |
0.901
|
|
|
|
cellular response to radiation
|
GO:0071478 |
65 |
0.899
|
|
|
|
erythrocyte differentiation
|
GO:0030218 |
28 |
0.896
|
|
|
|
granulocyte chemotaxis
|
GO:0071621 |
37 |
0.896
|
|
|
|
regulation of rho protein signal transduction
|
GO:0035023 |
79 |
0.895
|
|
|
|
response to purine containing compound
|
GO:0014074 |
40 |
0.895
|
|
|
|
response to steroid hormone
|
GO:0048545 |
80 |
0.894
|
|
|
|
response to estrogen
|
GO:0043627 |
47 |
0.894
|
|
|
|
regulation of leukocyte differentiation
|
GO:1902105 |
61 |
0.892
|
|
|
|
actin filament based process
|
GO:0030029 |
224 |
0.890
|
|
|
|
positive regulation of nucleoside metabolic process
|
GO:0045979 |
186 |
0.890
|
|
|
|
cellular response to cytokine stimulus
|
GO:0071345 |
181 |
0.890
|
|
|
|
neuron apoptotic process
|
GO:0051402 |
39 |
0.888
|
|
|
|
negative regulation of apoptotic signaling pathway
|
GO:2001234 |
97 |
0.888
|
|
|
|
skin development
|
GO:0043588 |
76 |
0.886
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
289 |
0.886
|
|
|
|
regulation of dna metabolic process
|
GO:0051052 |
153 |
0.884
|
|
|
|
cell substrate junction assembly
|
GO:0007044 |
35 |
0.883
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
398 |
0.880
|
|
|
|
cell cycle g1 s phase transition
|
GO:0044843 |
80 |
0.879
|
|
|
|
membrane organization
|
GO:0061024 |
292 |
0.878
|
|
|
|
cardiovascular system development
|
GO:0072358 |
262 |
0.877
|
|
|
|
branching morphogenesis of an epithelial tube
|
GO:0048754 |
19 |
0.877
|
|
|
|
gastrulation
|
GO:0007369 |
51 |
0.873
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
228 |
0.870
|
|
|
|
dna packaging
|
GO:0006323 |
77 |
0.869
|
|
|
|
regulation of cell morphogenesis
|
GO:0022604 |
153 |
0.869
|
|
|
|
embryonic organ development
|
GO:0048568 |
36 |
0.868
|
|
|
|
signal transduction involved in dna integrity checkpoint
|
GO:0072401 |
15 |
0.868
|
|
|
|
wound healing
|
GO:0042060 |
115 |
0.865
|
|
|
|
signal transduction involved in mitotic dna integrity checkpoint
|
GO:1902403 |
13 |
0.864
|
|
|
|
regeneration
|
GO:0031099 |
4 |
0.862
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
38 |
0.857
|
|
|
|
response to growth factor
|
GO:0070848 |
205 |
0.854
|
|
|
|
regulation of cell matrix adhesion
|
GO:0001952 |
42 |
0.854
|
|
|
|
cell cell junction organization
|
GO:0045216 |
69 |
0.854
|
|
|
|
regulation of carbohydrate biosynthetic process
|
GO:0043255 |
27 |
0.853
|
|
|
|
negative regulation of transcription initiation from rna polymerase ii promoter
|
GO:0060633 |
3 |
0.852
|
|
|
|
circulatory system development
|
GO:0072359 |
262 |
0.846
|
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
264 |
0.845
|
|
|
|
interleukin 1 alpha secretion
|
GO:0050703 |
1 |
0.845
|
|
|
|
guanosine containing compound catabolic process
|
GO:1901069 |
239 |
0.844
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
162 |
0.842
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
313 |
0.842
|
|
|
|
regulation of innate immune response
|
GO:0045088 |
97 |
0.835
|
|
|
|
positive regulation of nucleotide metabolic process
|
GO:0045981 |
230 |
0.835
|
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
207 |
0.834
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
50 |
0.833
|
|
|
|
behavior
|
GO:0007610 |
112 |
0.829
|
|
|
|
peptidyl serine phosphorylation
|
GO:0018105 |
101 |
0.828
|
|
|
|
vesicle mediated transport
|
GO:0016192 |
371 |
0.827
|
|
|
|
regulation of cellular component movement
|
GO:0051270 |
334 |
0.826
|
|
|
|
membrane raft assembly
|
GO:0001765 |
7 |
0.822
|
|
|
|
membrane biogenesis
|
GO:0044091 |
13 |
0.817
|
|
|
|
positive regulation of t cell apoptotic process
|
GO:0070234 |
4 |
0.814
|
|
|
|
mitochondrion organization
|
GO:0007005 |
156 |
0.814
|
|
|
|
embryo development
|
GO:0009790 |
123 |
0.813
|
|
|
|
substantia nigra development
|
GO:0021762 |
45 |
0.806
|
|
|
|
leukocyte aggregation
|
GO:0070486 |
8 |
0.805
|
|
|
|
secretion by cell
|
GO:0032940 |
226 |
0.801
|
|
|
|
inflammatory response
|
GO:0006954 |
79 |
0.800
|
|
|
|
negative regulation of cell cycle g1 s phase transition
|
GO:1902807 |
29 |
0.800
|
|
|
|
fibroblast proliferation
|
GO:0048144 |
33 |
0.797
|
|
|
|
protein oligomerization
|
GO:0051259 |
173 |
0.797
|
|
|
|
regulation of synaptic plasticity
|
GO:0048167 |
3 |
0.795
|
|
|
|
response to oxygen containing compound
|
GO:1901700 |
369 |
0.792
|
|
|
|
covalent chromatin modification
|
GO:0016569 |
254 |
0.791
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
404 |
0.788
|
|
|
|
regulation of proteasomal ubiquitin dependent protein catabolic process
|
GO:0032434 |
71 |
0.787
|
|
|
|
regulation of purine nucleotide catabolic process
|
GO:0033121 |
205 |
0.787
|
|
|
|
response to light stimulus
|
GO:0009416 |
87 |
0.784
|
|
|
|
regulation of response to external stimulus
|
GO:0032101 |
222 |
0.784
|
|
|
|
response to hormone
|
GO:0009725 |
175 |
0.784
|
|
|
|
positive regulation of cellular component biogenesis
|
GO:0044089 |
158 |
0.784
|
|
|
|
autophagy
|
GO:0006914 |
88 |
0.783
|
|
|
|
epithelial cell differentiation
|
GO:0030855 |
141 |
0.783
|
|
|
|
negative regulation of multi organism process
|
GO:0043901 |
92 |
0.777
|
|
|
|
positive regulation of rho gtpase activity
|
GO:0032321 |
56 |
0.772
|
|
|
|
positive regulation of cell cycle process
|
GO:0090068 |
106 |
0.771
|
|
|
|
hair follicle morphogenesis
|
GO:0031069 |
2 |
0.765
|
|
|
|
cell matrix adhesion
|
GO:0007160 |
85 |
0.765
|
|
|
|
actomyosin structure organization
|
GO:0031032 |
59 |
0.764
|
|
|
|
response to bacterium
|
GO:0009617 |
144 |
0.764
|
|
|
|
regulation of cell motility
|
GO:2000145 |
299 |
0.751
|
|
|
|
dna damage response signal transduction by p53 class mediator resulting in cell cycle arrest
|
GO:0006977 |
9 |
0.750
|
|
|
|
interleukin 1 production
|
GO:0032612 |
26 |
0.740
|
|
|
|
negative regulation of immune system process
|
GO:0002683 |
136 |
0.740
|
|
|
|
response to ionizing radiation
|
GO:0010212 |
65 |
0.738
|
Zebrafish |
|
|
protein stabilization
|
GO:0050821 |
64 |
0.738
|
Human |
|
|
single organism cell adhesion
|
GO:0098602 |
179 |
0.735
|
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.734
|
|
|
|
regulation of leukocyte migration
|
GO:0002685 |
63 |
0.734
|
|
|
|
regulation of actin cytoskeleton organization
|
GO:0032956 |
116 |
0.730
|
|
|
|
negative regulation of myeloid cell differentiation
|
GO:0045638 |
42 |
0.729
|
|
|
|
establishment of protein localization to membrane
|
GO:0090150 |
121 |
0.729
|
|
|
|
protein localization to membrane
|
GO:0072657 |
160 |
0.728
|
|
|
|
chromatin assembly or disassembly
|
GO:0006333 |
78 |
0.725
|
|
|
|
cellular senescence
|
GO:0090398 |
34 |
0.722
|
|
|
|
response to lipid
|
GO:0033993 |
206 |
0.720
|
|
|
|
midbrain development
|
GO:0030901 |
45 |
0.719
|
|
|
|
hexose metabolic process
|
GO:0019318 |
55 |
0.715
|
|
|
|
adherens junction organization
|
GO:0034332 |
36 |
0.714
|
|
|
|
positive regulation of nucleotide catabolic process
|
GO:0030813 |
185 |
0.714
|
|
|
|
negative regulation of response to external stimulus
|
GO:0032102 |
83 |
0.697
|
|
|
|
renal system development
|
GO:0072001 |
63 |
0.696
|
|
|
|
monocyte chemotaxis
|
GO:0002548 |
20 |
0.695
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
11 |
0.691
|
|
|
|
peptidyl threonine phosphorylation
|
GO:0018107 |
41 |
0.691
|
|
|
|
epidermal cell differentiation
|
GO:0009913 |
45 |
0.690
|
|
|
|
regulation of signal transduction by p53 class mediator
|
GO:1901796 |
26 |
0.682
|
|
|
|
enzyme linked receptor protein signaling pathway
|
GO:0007167 |
303 |
0.682
|
|
|
|
hindbrain development
|
GO:0030902 |
3 |
0.679
|
|
|
|
negative regulation of developmental process
|
GO:0051093 |
247 |
0.676
|
|
|
|
vasculature development
|
GO:0001944 |
181 |
0.673
|
|
|
|
regulation of notch signaling pathway
|
GO:0008593 |
18 |
0.673
|
|
|
|
positive regulation of purine nucleotide metabolic process
|
GO:1900544 |
227 |
0.672
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
281 |
0.670
|
|
|
|
taxis
|
GO:0042330 |
157 |
0.669
|
|
|
|
positive regulation of focal adhesion assembly
|
GO:0051894 |
11 |
0.669
|
|
|
|
cell junction assembly
|
GO:0034329 |
67 |
0.667
|
|
|
|
positive regulation of sequence specific dna binding transcription factor activity
|
GO:0051091 |
131 |
0.667
|
|
|
|
metal ion transport
|
GO:0030001 |
272 |
0.665
|
|
|
|
neutrophil chemotaxis
|
GO:0030593 |
24 |
0.664
|
|
|
|
intrinsic apoptotic signaling pathway in response to dna damage by p53 class mediator
|
GO:0042771 |
23 |
0.664
|
|
|
|
negative regulation of protein phosphorylation
|
GO:0001933 |
140 |
0.657
|
|
|
|
positive regulation of cytoskeleton organization
|
GO:0051495 |
83 |
0.651
|
|
|
|
neurogenesis
|
GO:0022008 |
169 |
0.647
|
|
|
|
ion transmembrane transport
|
GO:0034220 |
338 |
0.646
|
|
|
|
negative regulation of catalytic activity
|
GO:0043086 |
335 |
0.644
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
80 |
0.641
|
|
|
|
extrinsic apoptotic signaling pathway
|
GO:0097191 |
119 |
0.639
|
|
|
|
dna damage response signal transduction resulting in transcription
|
GO:0042772 |
12 |
0.626
|
|
|
|
cellular response to oxygen containing compound
|
GO:1901701 |
276 |
0.621
|
|
|
|
protein targeting
|
GO:0006605 |
187 |
0.619
|
|
|
|
double strand break repair
|
GO:0006302 |
101 |
0.618
|
|
|
|
gland development
|
GO:0048732 |
48 |
0.612
|
|
|
|
intracellular steroid hormone receptor signaling pathway
|
GO:0030518 |
61 |
0.607
|
|
|
|
organelle assembly
|
GO:0070925 |
176 |
0.606
|
|
|
|
single organism cellular localization
|
GO:1902580 |
332 |
0.606
|
|
|
|
oxidation reduction process
|
GO:0055114 |
396 |
0.605
|
|
|
|
digestive tract morphogenesis
|
GO:0048546 |
56 |
0.605
|
|
|
|
regulation of protein catabolic process
|
GO:0042176 |
155 |
0.602
|
|
|
|
regulation of cell junction assembly
|
GO:1901888 |
29 |
0.602
|
|
|
|
blood vessel development
|
GO:0001568 |
172 |
0.600
|
|
|
|
nuclear division
|
GO:0000280 |
128 |
0.598
|
|
|
|
chromosome segregation
|
GO:0007059 |
114 |
0.598
|
|
|
|
single organismal cell cell adhesion
|
GO:0016337 |
148 |
0.597
|
|
|
|
androgen receptor signaling pathway
|
GO:0030521 |
34 |
0.597
|
|
|
|
regulation of gtp catabolic process
|
GO:0033124 |
180 |
0.595
|
|
|
|
regulation of cellular protein catabolic process
|
GO:1903362 |
96 |
0.593
|
|
|
|
stress activated protein kinase signaling cascade
|
GO:0031098 |
94 |
0.591
|
|
|
|
regulation of cellular component size
|
GO:0032535 |
82 |
0.589
|
|
|
|
regulation of ras gtpase activity
|
GO:0032318 |
128 |
0.589
|
|
|
|
negative regulation of phosphorylation
|
GO:0042326 |
174 |
0.587
|
|
|
|
stress fiber assembly
|
GO:0043149 |
40 |
0.587
|
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
267 |
0.583
|
|
|
|
actin filament organization
|
GO:0007015 |
128 |
0.582
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
244 |
0.580
|
|
|
|
regulation of protein serine threonine kinase activity
|
GO:0071900 |
179 |
0.577
|
|
|
|
columnar cuboidal epithelial cell differentiation
|
GO:0002065 |
14 |
0.574
|
|
|
|
notch signaling pathway
|
GO:0007219 |
31 |
0.573
|
|
|
|
single organism carbohydrate metabolic process
|
GO:0044723 |
193 |
0.571
|
|
|
|
morphogenesis of a branching epithelium
|
GO:0061138 |
20 |
0.569
|
|
|
|
regulation of metal ion transport
|
GO:0010959 |
120 |
0.568
|
|
|
|
histone h4 acetylation
|
GO:0043967 |
47 |
0.567
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
92 |
0.566
|
|
|
|
angiogenesis
|
GO:0001525 |
147 |
0.564
|
|
|
|
positive regulation of organelle organization
|
GO:0010638 |
195 |
0.562
|
|
|
|
t cell activation
|
GO:0042110 |
99 |
0.562
|
|
|
|
leukocyte chemotaxis
|
GO:0030595 |
76 |
0.560
|
|
|
|
positive regulation of cell matrix adhesion
|
GO:0001954 |
23 |
0.559
|
|
|
|
neural nucleus development
|
GO:0048857 |
47 |
0.558
|
|
|
|
regulation of actin filament bundle assembly
|
GO:0032231 |
36 |
0.558
|
|
|
|
digestive system development
|
GO:0055123 |
75 |
0.556
|
|
|
|
signal transduction by p53 class mediator
|
GO:0072331 |
72 |
0.553
|
|
|
|
gtp metabolic process
|
GO:0046039 |
239 |
0.548
|
|
|
|
regulation of gtpase activity
|
GO:0043087 |
180 |
0.544
|
|
|
|
regulation of substrate adhesion dependent cell spreading
|
GO:1900024 |
19 |
0.544
|
|
|
|
transforming growth factor beta receptor signaling pathway
|
GO:0007179 |
76 |
0.540
|
|
|
|
circadian regulation of gene expression
|
GO:0032922 |
8 |
0.540
|
|
|
|
positive regulation of proteasomal protein catabolic process
|
GO:1901800 |
35 |
0.538
|
|
|
|
calcium ion transport
|
GO:0006816 |
147 |
0.538
|
|
|
|
response to fungus
|
GO:0009620 |
4 |
0.537
|
|
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
75 |
0.532
|
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
190 |
0.531
|
|
|
|
protein polyubiquitination
|
GO:0000209 |
110 |
0.529
|
|
|
|
digestive tract development
|
GO:0048565 |
75 |
0.528
|
|
|
|
focal adhesion assembly
|
GO:0048041 |
30 |
0.526
|
|
|
|
positive regulation of cellular component organization
|
GO:0051130 |
376 |
0.523
|
|
|
|
cell substrate adherens junction assembly
|
GO:0007045 |
30 |
0.521
|
|
|
|
regulation of glucose metabolic process
|
GO:0010906 |
28 |
0.517
|
|
|
|
negative regulation of response to extracellular stimulus
|
GO:0032105 |
5 |
0.516
|
|
|
|
positive regulation of immune response
|
GO:0050778 |
159 |
0.511
|
|
|
|
positive regulation of gtp catabolic process
|
GO:0033126 |
166 |
0.510
|
|
|
|
regulation of translation
|
GO:0006417 |
89 |
0.509
|
|
|
|
intrinsic apoptotic signaling pathway by p53 class mediator
|
GO:0072332 |
37 |
0.508
|
|
|
|
response to estradiol
|
GO:0032355 |
23 |
0.504
|
|
|
|
regulation of ossification
|
GO:0030278 |
58 |
0.502
|
|
|
|
replicative senescence
|
GO:0090399 |
8 |
0.497
|
|
|
|
organelle fission
|
GO:0048285 |
149 |
0.496
|
|
|
|
regulation of neural precursor cell proliferation
|
GO:2000177 |
4 |
0.495
|
|
|
|
cell chemotaxis
|
GO:0060326 |
112 |
0.494
|
|
|
|
response to uv
|
GO:0009411 |
73 |
0.493
|
|
|
|
response to antibiotic
|
GO:0046677 |
15 |
0.491
|
|
|
|
regulation of stress fiber assembly
|
GO:0051492 |
32 |
0.491
|
|
|
|
positive regulation of immune system process
|
GO:0002684 |
283 |
0.490
|
|
|
|
neuron development
|
GO:0048666 |
113 |
0.489
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
391 |
0.489
|
Human |
|
|
female gamete generation
|
GO:0007292 |
2 |
0.489
|
|
|
|
immune response regulating signaling pathway
|
GO:0002764 |
97 |
0.487
|
|
|
|
chromatin assembly
|
GO:0031497 |
61 |
0.486
|
|
|
|
protein tetramerization
|
GO:0051262 |
47 |
0.482
|
|
|
|
mitotic nuclear division
|
GO:0007067 |
119 |
0.476
|
|
|
|
positive regulation of fibroblast apoptotic process
|
GO:2000271 |
6 |
0.471
|
|
|
|
canonical wnt signaling pathway
|
GO:0060070 |
116 |
0.467
|
|
|
|
positive regulation of phosphorylation
|
GO:0042327 |
394 |
0.466
|
|
|
|
vesicle organization
|
GO:0016050 |
62 |
0.466
|
|
|
|
pml body organization
|
GO:0030578 |
2 |
0.464
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
98 |
0.463
|
|
|
|
adherens junction assembly
|
GO:0034333 |
34 |
0.463
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
355 |
0.459
|
|
|
|
immune response
|
GO:0006955 |
307 |
0.455
|
|
|
|
leukocyte cell cell adhesion
|
GO:0007159 |
37 |
0.453
|
|
|
|
lens development in camera type eye
|
GO:0002088 |
2 |
0.452
|
|
|
|
glucose homeostasis
|
GO:0042593 |
31 |
0.451
|
|
|
|
positive regulation of response to wounding
|
GO:1903036 |
28 |
0.448
|
|
|
|
cellular polysaccharide biosynthetic process
|
GO:0033692 |
21 |
0.447
|
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
113 |
0.445
|
|
|
|
regulation of response to wounding
|
GO:1903034 |
101 |
0.441
|
|
|
|
muscle tissue development
|
GO:0060537 |
62 |
0.440
|
|
|
|
actin filament bundle assembly
|
GO:0051017 |
54 |
0.437
|
|
|
|
negative regulation of cellular carbohydrate metabolic process
|
GO:0010677 |
14 |
0.435
|
|
|
|
response to inorganic substance
|
GO:0010035 |
127 |
0.434
|
|
|
|
embryonic hemopoiesis
|
GO:0035162 |
4 |
0.431
|
|
|
|
toll like receptor 4 signaling pathway
|
GO:0034142 |
12 |
0.428
|
|
|
|
ossification
|
GO:0001503 |
121 |
0.428
|
|
|
|
skin morphogenesis
|
GO:0043589 |
6 |
0.427
|
|
|
|
positive regulation of cell motility
|
GO:2000147 |
177 |
0.427
|
|
|
|
negative regulation of cardiac muscle tissue growth
|
GO:0055022 |
2 |
0.426
|
|
|
|
negative regulation of protein transport
|
GO:0051224 |
75 |
0.424
|
|
|
|
regulation of potassium ion transmembrane transport
|
GO:1901379 |
20 |
0.422
|
|
|
|
carbohydrate biosynthetic process
|
GO:0016051 |
42 |
0.420
|
|
|
|
cellular component disassembly
|
GO:0022411 |
92 |
0.416
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
128 |
0.416
|
|
|
|
actin filament bundle organization
|
GO:0061572 |
54 |
0.414
|
|
|
|
metencephalon development
|
GO:0022037 |
2 |
0.413
|
|
|
|
negative regulation of multicellular organismal process
|
GO:0051241 |
317 |
0.409
|
|
|
|
male sex differentiation
|
GO:0046661 |
25 |
0.406
|
|
|
|
positive regulation of actin filament bundle assembly
|
GO:0032233 |
25 |
0.406
|
|
|
|
positive regulation of proteasomal ubiquitin dependent protein catabolic process
|
GO:0032436 |
30 |
0.405
|
|
|
|
centrosome cycle
|
GO:0007098 |
32 |
0.404
|
|
|
|
regulation of focal adhesion assembly
|
GO:0051893 |
20 |
0.395
|
|
|
|
activation of innate immune response
|
GO:0002218 |
55 |
0.394
|
|
|
|
response to alcohol
|
GO:0097305 |
64 |
0.392
|
|
|
|
dna damage response signal transduction by p53 class mediator
|
GO:0030330 |
44 |
0.387
|
|
|
|
cellular response to lipid
|
GO:0071396 |
127 |
0.385
|
|
|
|
eye development
|
GO:0001654 |
42 |
0.383
|
|
|
|
xenobiotic metabolic process
|
GO:0006805 |
28 |
0.382
|
|
|
|
membrane raft organization
|
GO:0031579 |
10 |
0.380
|
|
|
|
regulation of wnt signaling pathway
|
GO:0030111 |
123 |
0.379
|
|
|
|
regulation of carbohydrate metabolic process
|
GO:0006109 |
54 |
0.379
|
|
|
|
regulation of behavior
|
GO:0050795 |
82 |
0.378
|
|
|
|
positive regulation of protein ubiquitination
|
GO:0031398 |
53 |
0.378
|
|
|
|
ameboidal type cell migration
|
GO:0001667 |
135 |
0.378
|
|
|
|
patterning of blood vessels
|
GO:0001569 |
2 |
0.378
|
|
|
|
myeloid leukocyte differentiation
|
GO:0002573 |
60 |
0.376
|
|
|
|
male meiosis
|
GO:0007140 |
1 |
0.375
|
|
|
|
cellular response to transforming growth factor beta stimulus
|
GO:0071560 |
94 |
0.373
|
|
|
|
signal transduction involved in dna damage checkpoint
|
GO:0072422 |
15 |
0.373
|
|
|
|
generation of precursor metabolites and energy
|
GO:0006091 |
68 |
0.370
|
|
|
|
negative regulation of cardiac muscle cell proliferation
|
GO:0060044 |
2 |
0.364
|
|
|
|
cell adhesion
|
GO:0007155 |
325 |
0.360
|
|
|
|
regulation of neuroblast proliferation
|
GO:1902692 |
3 |
0.360
|
|
|
|
negative regulation of cysteine type endopeptidase activity involved in apoptotic process
|
GO:0043154 |
46 |
0.360
|
|
|
|
establishment of protein localization to plasma membrane
|
GO:0090002 |
68 |
0.360
|
|
|
|
positive regulation of cellular component movement
|
GO:0051272 |
181 |
0.358
|
|
|
|
regulation of cardiac muscle cell apoptotic process
|
GO:0010665 |
3 |
0.353
|
|
|
|
neutrophil migration
|
GO:1990266 |
25 |
0.351
|
|
